Ypsomed Holding AG (CHIX:YPSNZ) Debt-to-Equity : 0.00 (As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Ypsomed Holding AG Debt-to-Equity?

Ypsomed Holding AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was CHF0.0 Mil. Ypsomed Holding AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was CHF0.0 Mil. Ypsomed Holding AG's Total Stockholders Equity for the quarter that ended in Sep. 2023 was CHF573.7 Mil. Ypsomed Holding AG's debt to equity for the quarter that ended in Sep. 2023 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Ypsomed Holding AG's Debt-to-Equity or its related term are showing as below:

CHIX:YPSNz' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.04 Max: 0.68
Current: 0.27

During the past 13 years, the highest Debt-to-Equity Ratio of Ypsomed Holding AG was 0.68. The lowest was 0.02. And the median was 0.04.

CHIX:YPSNz's Debt-to-Equity is ranked worse than
56.12% of 711 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs CHIX:YPSNz: 0.27

Ypsomed Holding AG Debt-to-Equity Historical Data

The historical data trend for Ypsomed Holding AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG Debt-to-Equity Chart

Ypsomed Holding AG Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

Get a 7-Day Free Trial

0.03

0.51

0.54

0.68

0.28

Ypsomed Holding AG Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial															0.14	0.68	-	0.28	-

Competitive Comparison of Ypsomed Holding AG's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ypsomed Holding AG's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Debt-to-Equity falls into.

Ypsomed Holding AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Ypsomed Holding AG's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(157	+	0)	/	562.331
	=	0.28

Ypsomed Holding AG's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	573.691
	=	0.00

Ypsomed Holding AG (CHIX:YPSNz) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Ypsomed Holding AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Ypsomed Holding AG (CHIX:YPSNZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (CHIX:YPSNz) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

YPSN:Switzerland

Address

Brunnmattstrasse 6, Burgdorf, CHE, 3401

Website

https://www.ypsomed.com

Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (CHIX:YPSNZ) Headlines

No Headlines